Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(29%)
Results Posted
100%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_3
1
14%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 3Large-scale testing
1(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Recruiting2
Not yet recruiting2
unknown1
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (100.0%)

Trials by Status

recruiting229%
unknown114%
completed114%
not_yet_recruiting229%
terminated114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
7